# Embosphere® PROstate Post Market Study

> **NCT03527589** · — · COMPLETED · sponsor: **Merit Medical Systems, Inc.** · enrollment: 499 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia
- Lower Urinary Tract Symptoms

## Interventions

- **DEVICE:** Prostate artery embolization

## Key facts

- **NCT ID:** NCT03527589
- **Lead sponsor:** Merit Medical Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-16
- **Primary completion:** 2020-01-21
- **Final completion:** 2022-01-22
- **Target enrollment:** 499 (ACTUAL)
- **Last updated:** 2023-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03527589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03527589, "Embosphere® PROstate Post Market Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03527589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*